Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

IndexRUT P/E- EPS (ttm)-1.23 Insider Own58.55% Shs Outstand49.12M Perf Week16.12%
Market Cap154.47M Forward P/E- EPS next Y-0.55 Insider Trans-0.05% Shs Float20.52M Perf Month9.69%
Income-60.35M PEG- EPS next Q-0.20 Inst Own24.47% Short Float9.85% Perf Quarter37.83%
Sales93.22M P/S1.66 EPS this Y28.50% Inst Trans-7.40% Short Ratio15.01 Perf Half Y-25.67%
Book/sh0.45 P/B7.05 EPS next Y46.57% ROA-36.29% Short Interest2.02M Perf Year-15.69%
Cash/sh0.93 P/C3.42 EPS next 5Y- ROE-128.20% 52W Range1.88 - 6.31 Perf YTD-35.04%
Dividend Est.- P/FCF- EPS past 5Y-37.60% ROI-58.24% 52W High-49.76% Beta1.40
Dividend TTM- Quick Ratio1.98 Sales past 5Y23.82% Gross Margin53.01% 52W Low68.62% ATR (14)0.20
Dividend Ex-Date- Current Ratio2.73 EPS Y/Y TTM37.72% Oper. Margin-51.65% RSI (14)57.65 Volatility8.54% 6.46%
Employees330 Debt/Eq3.81 Sales Y/Y TTM9.66% Profit Margin-64.74% Recom2.00 Target Price4.80
Option/ShortYes / Yes LT Debt/Eq3.66 EPS Q/Q48.02% Payout- Rel Volume0.44 Prev Close3.22
Sales Surprise-1.13% EPS Surprise-1.35% Sales Q/Q-1.52% EarningsNov 14 AMC Avg Volume134.63K Price3.17
SMA206.31% SMA5011.47% SMA200-6.29% Trades Volume59,094 Change-1.55%
Date Action Analyst Rating Change Price Target Change
Aug-06-24Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-06-24Downgrade JP Morgan Overweight → Neutral
Aug-06-24Downgrade BTIG Research Buy → Neutral
Jun-21-24Initiated Craig Hallum Buy $7.50
Dec-14-23Initiated Guggenheim Neutral
Jul-05-23Resumed JP Morgan Overweight $18
Feb-02-23Initiated UBS Buy $14
Nov-03-22Initiated CapitalOne Overweight $19
Oct-06-22Initiated Stephens Overweight $16
Jun-22-22Initiated BTIG Research Buy $16
Nov-05-24 08:00AM
Oct-28-24 08:30AM
Oct-07-24 08:00AM
Oct-03-24 04:00PM
Aug-05-24 08:59PM
05:10PM Loading…
05:10PM
04:07PM
04:00PM
Jul-15-24 04:00PM
May-15-24 08:02AM
May-14-24 01:55PM
09:01AM
08:14AM
07:34AM
May-13-24 08:54PM
05:35PM Loading…
05:35PM
04:36PM
04:00PM
May-09-24 08:00AM
May-06-24 10:00AM
08:00AM
May-02-24 08:00AM
Apr-22-24 04:05PM
Apr-05-24 08:00AM
Mar-05-24 09:52AM
07:00AM
Mar-04-24 08:51PM
05:31PM
05:15PM
04:21PM
04:05PM Loading…
04:05PM
Feb-08-24 04:05PM
Feb-07-24 04:13AM
Jan-18-24 08:00AM
Jan-10-24 08:00AM
Jan-08-24 01:07AM
Jan-07-24 08:00AM
08:00AM
08:00AM
Jan-05-24 08:34AM
Dec-27-23 09:55AM
Dec-20-23 08:05AM
Nov-12-23 10:51AM
Nov-09-23 10:25AM
Nov-08-23 05:51PM
04:05PM
04:00PM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 09:00AM
Oct-17-23 10:22AM
Oct-11-23 04:05PM
Sep-19-23 08:00AM
Aug-17-23 09:56AM
Aug-08-23 12:38PM
Aug-07-23 06:15PM
05:02PM
04:05PM
08:05AM
Aug-06-23 10:57AM
Jul-26-23 04:05PM
Jul-21-23 09:21AM
Jul-12-23 09:55AM
08:05AM
Jul-10-23 10:08AM
Jun-13-23 07:58PM
12:32PM
08:29AM
06:37AM
Jun-12-23 04:05PM
Jun-08-23 12:55AM
Jun-07-23 04:08PM
May-09-23 10:43AM
May-08-23 05:35PM
04:32PM
04:05PM
May-05-23 07:36AM
Apr-27-23 08:00AM
Apr-17-23 12:20PM
Apr-14-23 03:38PM
Apr-12-23 08:00AM
08:00AM
Apr-06-23 08:00AM
Mar-20-23 04:00PM
Mar-09-23 05:17AM
Mar-08-23 07:21AM
Mar-07-23 09:52AM
Mar-06-23 05:35PM
04:05PM
Feb-28-23 08:00AM
Feb-27-23 10:00AM
Feb-10-23 06:36PM
Feb-06-23 08:05AM
Feb-01-23 08:00AM
Jan-08-23 04:00PM
Jan-06-23 08:00AM
Dec-28-22 04:00PM
Dec-15-22 04:00PM
Dec-07-22 05:15AM
Nov-07-22 05:25PM
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKelligon BrianPresident and CEOJun 11 '24Option Exercise0.307,5002,272232,233Jun 12 04:01 PM
McKelligon BrianPresident and CEOJun 11 '24Sale2.087,50015,630224,733Jun 12 04:01 PM
McKelligon BrianPresident and CEOJun 06 '24Option Exercise0.307,5002,272232,233Jun 07 09:56 PM
McKelligon BrianPresident and CEOJun 06 '24Sale2.017,50015,064224,733Jun 07 09:56 PM
McKelligon BrianPresident and CEOMar 20 '24Option Exercise0.307,5002,272239,368Mar 22 05:54 PM
McKelligon BrianPresident and CEOMar 20 '24Sale4.977,50037,243231,868Mar 22 05:54 PM
McKelligon BrianPresident and CEOMar 13 '24Sale4.947,50037,035224,368Mar 14 08:41 PM
McKelligon BrianPresident and CEODec 19 '23Option Exercise0.307,5002,272160,063Dec 20 07:16 PM
McKelligon BrianPresident and CEODec 19 '23Sale4.487,50033,566152,563Dec 20 07:16 PM
McKelligon BrianPresident and CEODec 12 '23Option Exercise0.307,5002,272160,063Dec 14 04:24 PM
McKelligon BrianPresident and CEODec 12 '23Sale4.257,50031,871152,563Dec 14 04:24 PM
McKelligon BrianPresident and CEONov 20 '23Option Exercise0.307,5002,272160,063Nov 22 04:00 PM
McKelligon BrianPresident and CEONov 20 '23Sale4.397,50032,901152,563Nov 22 04:00 PM
Last Close
Nov 08 04:00PM ET
0.9399
Dollar change
+0.0356
Percentage change
3.94
%
QSI Quantum-Si Incorporated daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.63 Insider Own31.75% Shs Outstand121.83M Perf Week22.35%
Market Cap139.08M Forward P/E- EPS next Y-0.79 Insider Trans0.55% Shs Float97.16M Perf Month19.31%
Income-89.35M PEG- EPS next Q-0.20 Inst Own36.18% Short Float6.08% Perf Quarter13.23%
Sales1.70M P/S81.81 EPS this Y1.47% Inst Trans0.64% Short Ratio12.12 Perf Half Y-44.71%
Book/sh1.64 P/B0.57 EPS next Y-18.08% ROA-29.89% Short Interest5.91M Perf Year-24.20%
Cash/sh1.47 P/C0.64 EPS next 5Y- ROE-32.58% 52W Range0.70 - 2.43 Perf YTD-53.24%
Dividend Est.- P/FCF- EPS past 5Y- ROI-38.30% 52W High-61.32% Beta3.00
Dividend TTM- Quick Ratio20.13 Sales past 5Y0.00% Gross Margin-223.38% 52W Low34.27% ATR (14)0.06
Dividend Ex-Date- Current Ratio20.57 EPS Y/Y TTM22.49% Oper. Margin-5999.65% RSI (14)63.36 Volatility8.12% 7.46%
Employees165 Debt/Eq0.01 Sales Y/Y TTM270.81% Profit Margin-5249.65% Recom2.00 Target Price2.75
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q9.96% Payout- Rel Volume1.08 Prev Close0.90
Sales Surprise-11.65% EPS Surprise13.51% Sales Q/Q203.41% EarningsNov 12 BMO Avg Volume487.35K Price0.94
SMA2016.92% SMA508.92% SMA200-28.44% Trades Volume528,321 Change3.94%
Date Action Analyst Rating Change Price Target Change
Dec-08-23Initiated H.C. Wainwright Buy $3
Sep-25-23Downgrade Canaccord Genuity Buy → Hold $3.50 → $2
Oct-20-21Initiated Canaccord Genuity Buy $13
Nov-07-24 04:01PM
Nov-05-24 09:00AM
Oct-31-24 03:35PM
Oct-30-24 06:00AM
Oct-23-24 06:00AM
05:21PM Loading…
Oct-17-24 05:21PM
Oct-10-24 06:00AM
Sep-24-24 06:00AM
Sep-19-24 06:00AM
Sep-04-24 06:00AM
Aug-27-24 06:01PM
04:30PM
Aug-26-24 06:00AM
Aug-07-24 04:02PM
Jul-30-24 04:05PM
04:05PM Loading…
Jul-17-24 04:05PM
Jul-09-24 03:56PM
Jun-10-24 09:00AM
May-31-24 08:00AM
May-30-24 04:05PM
May-09-24 04:01PM
Apr-30-24 08:30AM
Apr-18-24 04:05PM
Mar-21-24 04:05PM
Mar-07-24 12:01PM
Feb-29-24 04:05PM
Feb-27-24 08:30AM
Feb-09-24 08:00AM
Feb-05-24 08:00AM
Jan-18-24 08:30AM
08:30AM Loading…
Dec-12-23 08:30AM
Nov-15-23 08:30AM
Nov-11-23 09:18AM
Nov-09-23 04:05PM
Nov-08-23 08:15AM
Nov-01-23 08:30AM
Oct-31-23 08:00AM
Oct-17-23 08:30AM
Oct-05-23 06:36PM
08:00AM
Oct-03-23 08:00AM
Sep-21-23 08:00AM
Aug-22-23 07:05AM
Aug-16-23 04:00PM
Aug-14-23 06:02PM
Aug-07-23 08:00AM
Jul-26-23 08:00AM
Jul-18-23 04:00PM
Jun-21-23 08:00AM
Jun-07-23 08:00AM
May-25-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-11-23 04:00PM
May-02-23 08:00AM
Apr-24-23 08:00AM
Apr-20-23 08:00AM
Apr-14-23 08:00AM
Mar-24-23 08:00AM
Mar-06-23 08:00AM
Feb-17-23 08:00AM
Feb-13-23 04:00PM
Jan-09-23 08:00AM
08:00AM
08:00AM
Dec-22-22 04:05PM
Dec-20-22 08:00AM
Dec-08-22 08:00AM
Nov-07-22 04:05PM
Nov-03-22 04:00PM
Oct-17-22 04:05PM
Oct-13-22 02:00PM
Oct-04-22 08:00AM
Aug-26-22 08:00AM
Aug-08-22 04:02PM
Jul-29-22 08:30AM
Jul-18-22 04:42PM
Jun-22-22 08:45AM
Jun-16-22 04:30PM
Jun-01-22 08:45AM
May-25-22 08:00AM
May-17-22 11:00AM
May-10-22 08:00AM
May-09-22 04:05PM
04:01PM
Apr-18-22 04:13PM
Mar-28-22 04:05PM
Mar-14-22 12:39PM
Feb-28-22 04:05PM
Feb-18-22 09:21AM
Feb-14-22 04:05PM
Feb-07-22 04:05PM
Jan-10-22 04:10PM
Jan-04-22 08:00AM
Dec-21-21 08:00AM
Dec-14-21 09:25AM
Dec-02-21 10:15AM
Nov-10-21 04:05PM
Nov-09-21 08:00AM
Nov-04-21 04:05PM
Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vieceli John S.Chief Product OfficerSep 23 '24Sale0.952,1922,073166,916Sep 25 04:24 PM
Vieceli John S.Chief Product OfficerSep 24 '24Sale0.932,1171,970164,799Sep 25 04:24 PM
Hawkins Jeffrey AlanPresident & CEOAug 09 '24Buy0.8525,00021,2721,003,757Aug 13 06:01 AM
LaPointe ChristianGeneral Counsel & Corp. Secr.Aug 09 '24Buy0.8625,00021,610571,710Aug 13 06:01 AM
Keyes Jeffry R.Chief Financial OfficerAug 09 '24Buy0.8750,00043,465446,820Aug 13 06:01 AM
Kummeth Charles R.DirectorAug 09 '24Buy0.87138,900120,926323,900Aug 13 06:01 AM
Kummeth Charles R.DirectorAug 12 '24Buy0.8931,10027,533355,000Aug 13 06:01 AM
Johnston GraceChief Commercial OfficerJun 21 '24Sale1.214,3595,262299,109Jun 25 07:18 PM
Johnston GraceChief Commercial OfficerJun 24 '24Sale1.203,1693,790295,940Jun 25 07:18 PM
Hawkins Jeffrey AlanPresident & CEOMar 14 '24Buy1.7625,00044,00025,000Mar 18 08:21 AM
LaPointe ChristianGeneral Counsel & Corp. Secr.Mar 15 '24Buy1.7410,00017,400257,693Mar 18 08:07 AM
Keyes Jeffry R.Chief Financial OfficerMar 05 '24Buy1.6150,00080,50050,000Mar 06 05:09 PM